| Primary |
| Hypertension |
63.6% |
| Cardiomyopathy |
6.6% |
| Atrial Fibrillation |
3.1% |
| Rheumatoid Arthritis |
2.6% |
| Diabetes Mellitus |
2.3% |
| Anxiety |
1.9% |
| Bipolar I Disorder |
1.9% |
| Dyslipidaemia |
1.9% |
| Arrhythmia |
1.6% |
| Depression |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Renal Transplant |
1.6% |
| Cardiac Index |
1.4% |
| Coronary Artery Disease |
1.4% |
| Sleep Disorder |
1.4% |
| Congestive Cardiomyopathy |
1.2% |
| Hypothyroidism |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Back Pain |
0.9% |
| Blood Cholesterol Increased |
0.9% |
|
| Renal Failure Acute |
11.4% |
| Vomiting |
9.3% |
| Toxic Skin Eruption |
8.6% |
| Hyponatraemia |
7.9% |
| Thrombocytopenia |
7.1% |
| Pneumonia |
6.4% |
| Urticaria |
6.4% |
| Pneumonitis |
5.7% |
| Pruritus |
5.0% |
| Bronchopneumonia |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Death |
2.9% |
| Orthostatic Hypotension |
2.9% |
| Prostate Cancer |
2.9% |
| Renal Failure |
2.9% |
| Syncope |
2.9% |
| Throat Tightness |
2.9% |
| Urinary Tract Infection |
2.9% |
| Visual Impairment |
2.9% |
| Cerebrovascular Accident |
2.1% |
|
| Secondary |
| Hypertension |
26.8% |
| Drug Use For Unknown Indication |
20.3% |
| Product Used For Unknown Indication |
13.4% |
| Rheumatoid Arthritis |
4.2% |
| Cardiac Disorder |
3.7% |
| Unevaluable Event |
3.6% |
| Diabetes Mellitus |
3.2% |
| Depression |
2.6% |
| Atrial Fibrillation |
2.5% |
| Lung Infection |
2.3% |
| Congestive Cardiomyopathy |
2.2% |
| Dyslipidaemia |
2.2% |
| Essential Hypertension |
2.2% |
| Arteriosclerosis Obliterans |
2.1% |
| Arteriosclerosis |
1.8% |
| Hypercholesterolaemia |
1.5% |
| Renal Transplant |
1.5% |
| Anxiety |
1.4% |
| Cardiomyopathy |
1.4% |
| Respiratory Distress |
1.2% |
|
| Renal Failure Acute |
23.7% |
| Renal Failure |
6.8% |
| Toxic Skin Eruption |
6.8% |
| Dermatitis Exfoliative Generalised |
5.1% |
| Pain In Extremity |
5.1% |
| Pyrexia |
5.1% |
| Rhabdomyolysis |
5.1% |
| Tongue Oedema |
5.1% |
| Visual Impairment |
5.1% |
| Gastrointestinal Haemorrhage |
4.2% |
| Dermatitis Psoriasiform |
3.4% |
| Thrombocytopenia |
3.4% |
| Weight Decreased |
3.4% |
| Agranulocytosis |
2.5% |
| Fall |
2.5% |
| Gingivitis Ulcerative |
2.5% |
| Hyperhidrosis |
2.5% |
| Hyponatraemic Syndrome |
2.5% |
| Malaise |
2.5% |
| Sopor |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.9% |
| Hypertension |
20.1% |
| Product Used For Unknown Indication |
16.4% |
| Diabetes Mellitus |
3.5% |
| Atrial Fibrillation |
3.3% |
| Prophylaxis |
3.1% |
| Type 2 Diabetes Mellitus |
2.8% |
| Hiv Infection |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Anxiety |
2.5% |
| Lung Infection |
2.4% |
| Pain |
2.3% |
| Depression |
2.2% |
| Breast Cancer |
2.0% |
| Hypercholesterolaemia |
1.8% |
| Insomnia |
1.7% |
| Neuroendocrine Carcinoma Of The Skin |
1.6% |
| Chronic Myeloid Leukaemia |
1.5% |
| Hepatitis C |
1.4% |
| Asthma |
1.4% |
|
| Vomiting |
18.9% |
| Renal Failure |
8.6% |
| Thrombocytopenia |
8.6% |
| Renal Failure Acute |
6.3% |
| Rhabdomyolysis |
5.0% |
| Toxic Skin Eruption |
5.0% |
| Weight Decreased |
5.0% |
| Syncope |
4.5% |
| Rectal Haemorrhage |
4.1% |
| Somnolence |
4.1% |
| Urticaria |
4.1% |
| Renal Failure Chronic |
3.6% |
| Pyrexia |
3.2% |
| Rash Maculo-papular |
3.2% |
| Renal Cancer |
3.2% |
| Death |
2.7% |
| Pneumonia |
2.7% |
| Subdural Haematoma |
2.7% |
| Toxic Epidermal Necrolysis |
2.7% |
| Coombs Positive Haemolytic Anaemia |
2.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
42.9% |
| Hypertension |
38.1% |
| Arteriosclerosis |
7.1% |
| Lung Infection |
4.8% |
| Diabetes Mellitus |
2.4% |
| Pain |
2.4% |
| Type 1 Diabetes Mellitus |
2.4% |
|
| Hyponatraemia |
30.8% |
| Traumatic Brain Injury |
23.1% |
| Orthostatic Hypotension |
15.4% |
| Renal Tubular Necrosis |
15.4% |
| Malaise |
7.7% |
| Tachycardia |
7.7% |
|
